Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 7/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 5/20 | 0.37 |
| ▸ | APAF1 | O14727 | 4/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | CCR6 | P51684 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.36 |
| ▸ | MAPT | P10636 | 7/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15020256 | 1.00 | IDO1 (0.37) | IDO1L3MBTL1KMT2AMAPK1GPR55 | |
| SCHEMBL15020330 | 0.90 | IDO1 (0.39) | IDO1L3MBTL1KMT2AMAPK1GPR55 | |
| SCHEMBL15019794 | 0.90 | IDO1 (0.39) | IDO1L3MBTL1KMT2AMAPK1GPR55 | |
| SCHEMBL15020326 | 0.84 | L3MBTL1 (0.34) | L3MBTL1KMT2AMAPK1GPR55MEN1 | |
| SCHEMBL15020327 | 0.84 | L3MBTL1 (0.34) | L3MBTL1KMT2AMAPK1GPR55MEN1 | |
| SCHEMBL16426683 | 0.82 | RAB9A (0.48) | IDO1L3MBTL1KMT2AMAPK1MEN1 | |
| SCHEMBL16413878 | 0.81 | DNM1 (0.37) | L3MBTL1KMT2AMAPK1GPR55MEN1 | |
| SCHEMBL16426691 | 0.81 | DNM1 (0.37) | L3MBTL1KMT2AMAPK1GPR55MEN1 | |
| SCHEMBL16413881 | 0.81 | DNM1 (0.37) | L3MBTL1KMT2AMAPK1GPR55MEN1 | |
| SCHEMBL16426689 | 0.80 | IDO1 (0.43) | IDO1L3MBTL1KMT2AMAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9439844-B2 | Tri-aromatic azomethine direct dyes comprising at least one unit derived from resorcinol, dyeing composition, method and use | L'OREAL (FR) | 2016-09-13 | — | — | US | claimed |
| US-20150027483-A1 | TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE | L'OREAL (FR) | 2015-01-29 | — | — | US | claimed |
| EP-2791251-A1 | TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE | L'OREAL (FR) | 2014-10-22 | — | — | EP | claimed |
| WO-2013087772-A1 | TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE | L'OREAL (FR) | 2013-06-20 | — | — | WO | claimed |
| US-9439844-B2 | Tri-aromatic azomethine direct dyes comprising at least one unit derived from resorcinol, dyeing composition, method and use | L'OREAL (FR) | 2016-09-13 | — | — | US | disclosed |
| US-20150027483-A1 | TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE | L'OREAL (FR) | 2015-01-29 | — | — | US | disclosed |
| EP-2791251-A1 | TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE | L'OREAL (FR) | 2014-10-22 | — | — | EP | disclosed |
| WO-2013087772-A1 | TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE | L'OREAL (FR) | 2013-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150027483-A1 | TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE | KRT18, IK, MKI67 | IDO1 264/4885L3MBTL1 4835/4885KMT2A 948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.